US Patent Issued to Synthis Therapeutics on Nov. 18 for "Antibody-ALK5 inhibitor conjugates and their uses" (New Jersey Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,377, issued on Nov. 18, was assigned to Synthis Therapeutics Inc. (New York).

"Antibody-ALK5 inhibitor conjugates and their uses" was invented by Dori A. Thomas-Karyat (Jersey City, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibody-drug conjugates comprising ALK5 inhibitors and their uses."

The patent was filed on Dec. 23, 2022, under Application No. 18/146,269.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12473377&OS=12473377&RS=1247...